{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:33:32Z","timestamp":1790969612868,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ecl.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T18:47:49Z","timestamp":1525978069000},"page":"409-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["The Ectopic Adrenocorticotropic Hormone Syndrome"],"prefix":"10.1016","volume":"47","author":[{"given":"Aimee R.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2018.01.005_bib2","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/1097-0142(197505)35:5<1430::AID-CNCR2820350529>3.0.CO;2-O","article-title":"Studies on ectopic ACTH-producing tumors. II. Clinical and biochemical features of 30 cases","volume":"35","author":"Imura","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.ecl.2018.01.005_bib4","first-page":"283","article-title":"Clinical and laboratory studies of ectopic humoral syndromes","volume":"25","author":"Liddle","year":"1969","journal-title":"Recent Prog Horm Res"},{"issue":"8","key":"10.1016\/j.ecl.2018.01.005_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1590\/S0004-27302007000800007","article-title":"Ectopic ACTH syndrome","volume":"51","author":"Isidori","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"9996","key":"10.1016\/j.ecl.2018.01.005_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ecl.2018.01.005_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archinte.1993.00410060054009","article-title":"Ectopic corticotropin syndrome and small-cell carcinoma of the lung: clinical features, outcome, and complications","volume":"153","author":"Delisle","year":"1993","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ecl.2018.01.005_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/JTO.0000000000000116","article-title":"Prognostic impact of paraneoplastic Cushing's syndrome in small-cell lung cancer","volume":"9","author":"Nagy-Mignotte","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.ecl.2018.01.005_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/thy.2005.15.618","article-title":"Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature","volume":"15","author":"Barbosa","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.ecl.2018.01.005_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000472255","article-title":"Thymic neuroendocrine neoplasms: biological behaviour and therapy","volume":"105","author":"Jia","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1677\/joe.1.05963","article-title":"Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids","volume":"185","author":"Ye","year":"2005","journal-title":"J\u00a0Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/mend.15.2.0599","article-title":"The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression","volume":"15","author":"Newell-Price","year":"2001","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2018.01.005_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing\u2019s syndrome due to neuroendocrine tumors: a multicenter study","volume":"176","author":"Davi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0889-8529(01)00025-1","article-title":"Ectopic pro-opiomelanocortin syndrome","volume":"31","author":"Beuschlein","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.ecl.2018.01.005_bib17","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2005-0070","article-title":"Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas","volume":"90","author":"Woo","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.01.005_bib18","first-page":"160018","article-title":"A\u00a0thymic neuroendocrine tumour in a young female: a rare cause of relapsing and remitting Cushing\u2019s syndrome","volume":"2016","author":"Trott","year":"2016","journal-title":"Endocrinol Diabetes Metab case Rep"},{"issue":"9","key":"10.1016\/j.ecl.2018.01.005_bib19","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2018.01.005_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ncpendmet0327","article-title":"Cushing's syndrome caused by an occult source: difficulties in diagnosis and management","volume":"2","author":"Grossman","year":"2006","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0889-8529(05)70124-9","article-title":"Pituitary incidentalomas","volume":"29","author":"Aron","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9522","key":"10.1016\/j.ecl.2018.01.005_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ecl.2018.01.005_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1210\/jcem-20-12-1539","article-title":"Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome","volume":"20","author":"Liddle","year":"1960","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9343(68)90240-4","article-title":"Cushing's syndrome caused by bronchial adenomas","volume":"44","author":"Strott","year":"1968","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ecl.2018.01.005_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0026-0495(79)90097-0","article-title":"Cushing's syndrome: a review of diagnostic tests","volume":"28","author":"Crapo","year":"1979","journal-title":"Metabolism"},{"issue":"8506","key":"10.1016\/j.ecl.2018.01.005_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(86)90113-3","article-title":"The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome","volume":"328","author":"Hermus","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2265.1988.tb00258.x","article-title":"CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test","volume":"29","author":"Grossman","year":"1988","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.78.2.8106630","article-title":"A\u00a0comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"78","author":"Dichek","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2018.01.005_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-116-3-211","article-title":"Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome","volume":"116","author":"Flack","year":"1992","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2265.1986.tb01667.x","article-title":"Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production","volume":"24","author":"Howlett","year":"1986","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-104-2-180","article-title":"An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing\u2019s syndrome","volume":"104","author":"Tyrrell","year":"1986","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ecl.2018.01.005_bib32","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1210\/jc.2003-030510","article-title":"Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing\u2019s syndrome","volume":"88","author":"Isidori","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/eje.1.02278","article-title":"Ectopic ACTH syndrome: our experience with 25 cases","volume":"155","author":"Salgado","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib34","first-page":"647","article-title":"The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states","volume":"19","author":"Newell-Price","year":"1998","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib35","first-page":"1780","article-title":"Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing\u2019s syndrome","volume":"82","author":"Aron","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib36","first-page":"1308","article-title":"A\u00a0simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"77","author":"Nieman","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.01.005_bib37","first-page":"1640","article-title":"Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome","volume":"87","author":"Newell-Price","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.01.005_bib38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-76-3-112-6-434","article-title":"The Cushing syndrome: an update on diagnostic tests","volume":"112","author":"Kaye","year":"1990","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-69-1-165","article-title":"The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease","volume":"69","author":"Nieman","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jcem-57-5-963","article-title":"Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders","volume":"57","author":"Nakahara","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2018.01.005_bib41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJM198403083101004","article-title":"The corticotropin-releasing factor stimulation test: an aid in the evaluation of patients with Cushing's syndrome","volume":"310","author":"Chrousos","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2018.01.005_bib42","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/jc.2013-1992","article-title":"A\u00a0cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications","volume":"98","author":"Luque","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.01.005_bib43","first-page":"1646","article-title":"The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion","volume":"87","author":"Tsagarakis","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib44","first-page":"173","article-title":"The desmopressin test and Cushing's syndrome: current state of play","volume":"47","author":"Newell-Price","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1997.3091129.x","article-title":"Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in\u00a0vivo and in\u00a0vitro","volume":"47","author":"Arlt","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.7326\/0003-4819-105-6-862","article-title":"The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome","volume":"105","author":"Nieman","year":"1986","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib47","first-page":"440","article-title":"Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study","volume":"84","author":"Invitti","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2018.01.005_bib48","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib49","first-page":"487","article-title":"A\u00a0critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing\u2019s disease and the occult ectopic adrenocorticotropin syndrome","volume":"84","author":"Kaltsas","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2265.1996.d01-1550.x","article-title":"Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results","volume":"45","author":"Lopez","year":"1996","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib51","first-page":"1087","article-title":"False-positive inferior petrosal sinus sampling in the diagnosis of Cushing's disease: report of two cases","volume":"83","author":"Yamamoto","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"8","key":"10.1016\/j.ecl.2018.01.005_bib52","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1210\/jc.2003-032249","article-title":"Diagnostic errors after inferior petrosal sinus sampling","volume":"89","author":"Swearingen","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2018.01.005_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-8529(05)70209-7","article-title":"Diagnosis and differential diagnosis of Cushing's syndrome","volume":"30","author":"Findling","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib54","first-page":"533","article-title":"The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing\u2019s disease","volume":"84","author":"Doppman","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib55","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1210\/jc.2012-3943","article-title":"The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing's disease","volume":"98","author":"Wind","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000658-198708000-00001","article-title":"Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival","volume":"206","author":"Norheim","year":"1987","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ecl.2018.01.005_bib57","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S1470-2045(17)30681-2","article-title":"Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial","volume":"18","author":"Ferolla","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ecl.2018.01.005_bib58","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","article-title":"Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids","volume":"26","author":"Caplin","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ecl.2018.01.005_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:PITU.0000011172.26649.df","article-title":"Characterisation of ACTH related peptides in ectopic Cushing's syndrome","volume":"6","author":"Oliver","year":"2003","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2214\/ajr.156.1.1845787","article-title":"Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT","volume":"156","author":"Doppman","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2011-1264","article-title":"Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion","volume":"97","author":"de Bruin","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.ecl.2018.01.005_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000314224","article-title":"Medical treatment of Cushing\u2019s syndrome: glucocorticoid receptor antagonists and mifepristone","volume":"92","author":"Castinetti","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2018.01.005_bib64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib65","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","article-title":"Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience","volume":"245","author":"Thompson","year":"2007","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ecl.2018.01.005_bib66","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Outcome of bilateral adrenalectomy in\u00a0Cushing's syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.1995.tb01865.x","article-title":"Pseudo-tumours of the thymus after correction of hypercortisolism in patients with ectopic ACTH syndrome: a report of five cases","volume":"42","author":"Tabarin","year":"1995","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-008-9082-4","article-title":"Somatostatin and dopamine receptors as targets for medical treatment of Cushing\u2019s syndrome","volume":"10","author":"de Bruin","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/jc.2006-0728","article-title":"Dopamine receptor expression and function in corticotroph ectopic tumors","volume":"92","author":"Pivonello","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.ecl.2018.01.005_bib70","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJM200506093522322","article-title":"Cabergoline plus lanreotide for ectopic Cushing's syndrome","volume":"352","author":"Pivonello","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/er.2000-0001","article-title":"The pathophysiological consequences of somatostatin receptor internalization and resistance","volume":"24","author":"Hofland","year":"2003","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ecl.2018.01.005_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2018.01.005_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/RLU.0000000000000971","article-title":"Ectopic corticotropin-producing neuroendocrine tumor of the pancreas treated with 177Lu DOTATATE induction and maintenance peptide receptor radionuclide therapy","volume":"41","author":"Makis","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"18","key":"10.1016\/j.ecl.2018.01.005_bib74","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ecl.2018.01.005_bib75","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00000478-199808000-00003","article-title":"Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid","volume":"22","author":"Travis","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ecl.2018.01.005_bib76","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.119.6.1647","article-title":"Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature","volume":"119","author":"Fink","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ecl.2018.01.005_bib77","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.athoracsur.2013.05.047","article-title":"Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance","volume":"96","author":"Lou","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.ecl.2018.01.005_bib78","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00268-005-0774-6","article-title":"7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly","volume":"31","author":"Perez","year":"2007","journal-title":"World J Surg"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918300070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918300070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:46Z","timestamp":1760175826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852918300070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0889852918300070"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2018.01.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ectopic Adrenocorticotropic Hormone Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}